VITT is a vaccine safety signal with adenoviral-based vectors. We know that VITT is a safety signal from adenoviral-based vectors. What made this safety signal discernible was the concurrent presentation of thrombocytopenia and thrombosis, a rare occurrence in the general population and those immunized with nonadenoviral-based SARS-CoV-2 vaccines..